Esposito Pamela

CIK 00017444252 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001744425

Recent Transactions

50 trades

Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-20$68.52/sh−200→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-20$67.99/sh−4,900→ 200 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-20$31.20/sh+3,000→ 3,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-20$66.68/sh−400→ 5,100 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-01-20−2,500→ 5,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2026-01-20−3,000→ 10,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2026-01-20$49.10/sh+2,500→ 5,500 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$27.67/sh+12,000→ 24,563 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$31.20/sh+3,000→ 27,563 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-17−12,000→ 0 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$82.34/sh−7,959→ 5,099 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-17−3,000→ 13,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$81.56/sh−14,505→ 13,058 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-12-17−12,563→ 7,500 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$83.45/sh−4,099→ 1,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$84.07/sh−1,000→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-12-17$49.10/sh+12,563→ 12,563 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-25+16,000→ 16,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2025-06-03−5,000→ 24,127 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$49.04/sh−5,000→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2025-06-03$29.55/sh+5,000→ 5,000 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-12-02$29.55/sh+2,500→ 2,500 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-12-02−2,500→ 29,127 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-12-02$49.00/sh−2,500→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-09-17−5,000→ 7,000 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-09-17$47.75/sh−6,350→ 7,150 total
Sale
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-09-17$48.75/sh−7,150→ 0 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-09-17$14.18/sh+5,000→ 13,500 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Common Stock
2024-09-17$29.55/sh+8,500→ 8,500 total
Exercise/Conversion
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-09-17−8,500→ 31,627 total
Award
Kymera Therapeutics, Inc.$KYMR
Stock Option (Right to Buy)
2024-06-18+16,000→ 16,000 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-09-12−300→ 86,033 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-09-12$3.30/sh+300→ 263,736 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-09-12$20.00/sh−300→ 263,436 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-09-11−5,358→ 86,333 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-09-11$20.01/sh−5,358→ 263,436 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-09-11$3.30/sh+5,358→ 268,794 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-08-22$15.50/sh+5,000→ 282,036 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-08-22$3.30/sh+13,600→ 277,036 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-08-22$20.01/sh−18,600→ 263,436 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-08-22−13,600→ 91,691 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-08-22−5,000→ 35,750 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-08-11−1,400→ 105,291 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-08-11$20.00/sh−1,400→ 263,436 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-08-11$3.30/sh+1,400→ 264,836 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-07-10$15.50/sh+5,000→ 283,436 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-07-10−15,000→ 106,691 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Employee Stock Option (right to buy)
2023-07-10−5,000→ 40,750 total
Sale
Replimune Group, Inc.$REPL
Common Stock
2023-07-10$21.63/sh−17,923→ 265,513 total
Exercise/Conversion
Replimune Group, Inc.$REPL
Common Stock
2023-07-10$3.30/sh+15,000→ 278,436 total

Companies

Recent Filings

Address

C/O KYMERA THERAPEUTICS, INC. 500 NORTH BEACON STREET, 4TH FLOOR

WATERTOWN, MA, 02472

View on SEC.gov